Cargando…

Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy

Detalles Bibliográficos
Autores principales:	Alexander, Gregory, Palmer, Joshua, Tuluc, Madalina, Lin, Jianqing, Hooper, D Craig, Lu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645293/ http://dx.doi.org/10.1186/2051-1426-3-S2-P143

Ejemplares similares

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
por: Alexander, Gregory S., et al.
Publicado: (2016)

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma
por: Atkins, Michael B, et al.
Publicado: (2015)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087
por: Chen, Robert, et al.
Publicado: (2015)

A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer
por: Katz, Matthew, et al.
Publicado: (2015)

A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)
por: Long, Georgina V, et al.
Publicado: (2015)

Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial
por: Haas, Naomi B, et al.
Publicado: (2015)

Covert oxygen supply failure measured using the LiDCO plus monitor
por: Jonas, M, et al.
Publicado: (2006)

Impact of renal scintigraphy in severe patients with acute renal failure
por: Ferreira, JF, et al.
Publicado: (2005)

Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure
por: Ostermann, M, et al.
Publicado: (2005)

Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
por: Shaikh, Saba S., et al.
Publicado: (2022)

Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction
por: Chen, Horng H, et al.
Publicado: (2009)

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
por: Grimaldi, Antonio Maria, et al.
Publicado: (2015)

Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients
por: Simeone, Ester, et al.
Publicado: (2015)

Role of dual phase MDCT in renal cancer – beyond the renal mass
por: Santosh, D, et al.
Publicado: (2014)

Screen failure in phase I HIV clinical trials in Soweto, South Africa: an opportunity for care
por: Laher, F, et al.
Publicado: (2012)

Incidence and outcome of acute renal failure necessitating renal replacement therapy after trauma
por: Beitland, S, et al.
Publicado: (2009)

Acute renal failure in obstetrics: risk factors and outcome
por: Haddad, Z, et al.
Publicado: (2007)

Nonconvulsive seizures and renal failure after intracerebral hemorrhage
por: Kurtz, P, et al.
Publicado: (2009)

Copeptin and acute renal failure in critically ill patients
por: Meyer, B, et al.
Publicado: (2008)

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
por: Hodi, F Stephen, et al.
Publicado: (2014)

Comparing diagnostic tests and biomarkers: trials in people with discordant test results
por: Hooper, Richard, et al.
Publicado: (2011)

A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol
por: Pryor, David, et al.
Publicado: (2021)

Analysis of the outcome of mechanical ventilation in patients with acute renal failure
por: Neto, JAA, et al.
Publicado: (2011)

Acute renal failure and other complications induced by cocaine abuse
por: Cheibub, J, et al.
Publicado: (2007)

Severely ill patients in acute renal failure and prognostic indexes
por: D'Avila, DO, et al.
Publicado: (2005)

Survey of acute renal failure in patients after cardiovascular surgery
por: Iguchi, N, et al.
Publicado: (2007)

Clinical evaluation of the new RIFLE criteria for acute renal failure
por: Hoste, E, et al.
Publicado: (2004)

Renal failure in obstetrics: epidemiology and outcome in the intensive care unit
por: Haddad, Z, et al.
Publicado: (2005)

Performance of the APACHE IV system in patients with acute renal failure
por: Dahhan, T, et al.
Publicado: (2009)

Rhabdomyolysis: early prognostication of renal failure and other adverse outcomes
por: Simpson, J, et al.
Publicado: (2015)

A Phase I, open-label, dose escalation study of MGA271 in combination with pembrolizumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck, or squamous cell non-small cell lung cancer
por: Baughman, Jan, et al.
Publicado: (2015)

Myocardial oxygenation is reduced in end-stage renal failure: a novel blood oxygen level dependant (BOLD)-cardiac MRI study
por: Parnham, Susie F, et al.
Publicado: (2014)

Evaluation of acute renal failure in surgical patients in the intensive care unit
por: Anami, EHT, et al.
Publicado: (2007)

Neutrophil gelatinase-associated lipocalin as an early indicator for postoperative renal failure
por: Marel, CD Van der, et al.
Publicado: (2010)

Elevated endocan levels are associated with development of renal failure in ARDS patients
por: Rahmania, L, et al.
Publicado: (2015)

Established renal markers for diagnosis and prognosis in acutely decompensated heart failure
por: Brand, M, et al.
Publicado: (2015)

Determination of risk factors for acute renal failure after cardiac surgery
por: Ayazoğlu, TA, et al.
Publicado: (2015)

A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus)
por: Weiss, Glen J, et al.
Publicado: (2017)

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC
por: Lemmon, Christopher A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5tij0bu8i105dp8u5fhc8egu2k